Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking your Wegovy injection one day ahead of your usual day is unlikely to cause harm, and the NHS guidance on weekly GLP-1 medicines allows some flexibility around the day of the week. That said, it should be an occasional adjustment rather than a habit, and your prescriber's instruction always takes priority. Wegovy is a prescription-only medicine, and any changes to how you use it are best confirmed with the clinician overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people assume that because semaglutide stays active in the body for around a week, a day's variation either way is completely meaningless. That's understandable — and partly true — but it misses something important. The licensed schedule is once weekly for a reason. The clinical trials that established Wegovy's safety and effectiveness used that fixed interval, and the dosing ladder from 0.25 mg up through 1.7 mg to 2.4 mg was designed around it. So while one early injection is not a medical emergency, treating the weekly schedule as loosely optional is a different matter.
The NHS patient information for semaglutide is clear: if you need to change the day you inject, you can, but you must leave at least four days between any two doses before settling into the new day. That minimum gap is the safety floor. One day early keeps you above it comfortably, which is why a single, occasional adjustment sits in a different category to regularly injecting five or six days after the last dose.
Semaglutide's half-life is approximately one week, meaning it accumulates to a steady state over several weeks of dosing. If you have ever wondered whether injecting semaglutide a day early is safe, the short answer is that compressing the interval once does nudge plasma levels slightly higher than usual, but the effect is modest. Doing it every week is the scenario that raises real concern.
There are entirely sensible reasons to shift your Wegovy day: a bank holiday disrupting your delivery, travel across time zones, a planned procedure, or simply wanting to move from Mondays to Sundays. These are the situations the official flexibility guidance is designed to accommodate. Moving one day earlier is well within what the prescribing information supports, provided the four-day minimum is respected.
Where caution is warranted is when the urge to inject early is driven by symptoms: nausea, appetite returning faster than usual, or anxiety about missing a dose. If your appetite feels like it is returning strongly before the week is up, that is useful clinical information worth sharing with your prescriber rather than self-correcting with an early injection. It may point to a dose titration conversation, not a scheduling fix.
It is also worth thinking about injection site rotation. Shifting your day does not change the need to vary between your abdomen, thigh, and upper arm, if anything, an unplanned early injection is a good moment to double-check you are not returning to the same spot. The question of which site works best comes up often and the answer depends partly on individual comfort, but rotation is non-negotiable whatever day you choose.
If you are uncertain whether your specific situation warrants moving the date, contact your prescribing service. Our support team is available seven days a week for exactly this kind of question.
The most common side effects associated with semaglutide (Wegovy) are gastrointestinal: nausea, loose stools, burping, and occasionally vomiting. According to the NHS medicines page for semaglutide, these effects are typically most noticeable after starting treatment or following a dose increase, and they generally settle within days to a couple of weeks for most people.
Compressing the interval even by one day means slightly elevated drug exposure, which could tip someone who is already managing mild nausea into a rougher few days. That is not a reason to avoid an occasional early injection, but it is worth knowing so you can plan: inject at a time when you can rest if needed, stay well hydrated, and eat smaller, lower-fat meals around the injection.
There are rarer but more serious symptoms that always warrant prompt medical attention regardless of when you injected: severe stomach pain that radiates toward the back, signs of a serious allergic reaction, or anything that feels significantly worse than your usual adjustment period. If in doubt, seek medical help and mention your medication. You can also report any unexpected reactions through the MHRA's Yellow Card scheme.
For a broader look at the effects of shifting your semaglutide timing, including what the evidence says about longer-term schedule changes, that resource covers the topic in more detail.
Consistency is what the once-weekly design is built around. The most effective approach most people find is anchoring their injection to something fixed in their week, the same morning, the same routine. When life gets in the way and a one-day shift is the practical answer, that is fine. It does not reset your progress, and it does not require you to start your titration schedule again.
What does matter is recording the change. If you are using a diary or app to track your doses, log the actual date rather than the planned one. That makes it easier to stay on track the following week and gives your prescriber an accurate picture if they ask about your schedule at review.
If you are considering Wegovy as a treatment and want to understand what private, clinically supervised access looks like, our weight-loss treatment overview explains the options. Or, if you are ready to talk to a prescriber about your specific situation, you can check your eligibility through a free consultation with nume's clinical team. For context on how Wegovy sits within the broader private treatment landscape, the cost context page covers what a legitimate private prescription typically includes.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.